You just read:

BLINCYTO® (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy

News provided by

Amgen

Mar 01, 2017, 17:09 ET